Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,445 reports matching your criteria)
  • Biochemical Reagents

    ... at a CAGR of 8.7% over the analysis period 2023-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$6.3 Billion by the end ... Read More

  • Biopharmaceutical Logistics

    ... at a CAGR of 4.8% over the analysis period 2023-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$37.9 Billion by the end ... Read More

  • Biopharmaceutical Fermentation Systems

    ... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More

  • Extracorporeal CO2 Removal Devices

    ... reach US$151.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and ... Read More

  • Vancomycin

    ... of 4.9% over the analysis period 2023-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis ... Read More

  • Travel Vaccines Market: Global Market Size, Forecast, Insights, and Competitive Landscape

    ... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global travel vaccines market by segmenting the market based on ... Read More

  • LED Video Walls

    ... by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by ... Read More

  • Nail Care

    ... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More

  • Patient Monitoring Devices

    ... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More

  • Probiotics Dietary Supplements

    ... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by ... Read More

  • Restorative Dentistry

    ... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More

  • Veterinary Pain Management

    ... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More

  • Industrial Protective Footwear

    ... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Leather Footwear, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$3.8 Billion by ... Read More

  • Ophthalmic Ultrasound Systems

    ... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Portable Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by ... Read More

  • Pre-Workout Supplements

    ... at a CAGR of 7.0% over the analysis period 2023-2030. Powder Supplements, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.7 Billion by the end of ... Read More

  • Radiodermatitis

    ... of 4.2% over the analysis period 2023-2030. Topical Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. ... Read More

  • Healthcare Cleanroom Consumables

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Cleanroom Apparels, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by ... Read More

  • Hospitals and Outpatient Care Centers

    ... is expected to reach US$5.1 Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.0 Trillion While China is Forecast to Grow at 7.6% ... Read More

  • Frozen Food

    ... at a CAGR of 6.4% over the analysis period 2023-2030. Frozen Raw Material, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$195.4 Billion by the end ... Read More

  • Medical Refrigerators

    ... at a CAGR of 6.9% over the analysis period 2023-2030. Blood Bank Refrigerator & Plasma Freezer, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion ... Read More

  • Self-Leveling Concrete

    ... at a CAGR of 4.3% over the analysis period 2023-2030. Underlayment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$7.0 Billion by the end of the ... Read More

  • Translucent Concrete

    ... at a CAGR of 41.5% over the analysis period 2023-2030. Concrete Raw Material, one of the segments analyzed in the report, is expected to record a 42.3% CAGR and reach US$118.5 Million by the end ... Read More

  • Underwater Concrete

    ... at a CAGR of 6.8% over the analysis period 2023-2030. Aggregates Raw Material, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$137.8 Billion by the end ... Read More

  • Biologics

    ... of 8.2% over the analysis period 2023-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis ... Read More

  • Chlamydia Infection Diagnostics and Therapeutics

    ... is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a ... Read More

Cookie Settings